The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2
Abroad (travel likely)RecruitingPHASE3
Conditions
Myotonic Dystrophy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Laboratory for Muscle Diseases and Neuropathies, Leuven, Belgium
Aarhus University Hospital, Aarhus, Denmark
Ludug-Maximilians University, München, Germany
Azienda Ospedaliera Universitaria Policlinico Tor Vergata, Rome, Italy
University Hospital of Madrid, Madrid, Spain
Saint George's University Hospitals NHS Foundation Trust, London, United Kingdom
University College Hospital, London, United Kingdom